News and blogs
422 results found.
MGUS to AML: Ian's Story & Blood Cancer Awareness
For Blood Cancer Awareness Month, Jonathan shares his story in memory of his dad Ian whose MGUS developed into Acute Myeloid Leukaemia. Ian sadly died in May 2022; just 8 weeks after his diagnosis.
Remember Her Majesty the Queen
Remember Her Majesty the Queen
What's the latest on Evusheld?
A look at the latest news on Evusheld
Blood cancer facts
Read about different blood cancer types, whether it's leukaemia, lymphoma, myeloma, MDS, or any other blood cancer.
Five things we learned about blood cancer services from the cancer patient experience survey
Every year, NHS England asks thousands of cancer patients in England about their experiences. We've picked out five key things we think the NHS and Government should be focusing on, which we believe would save a significant number of lives.
Leading charities and clinicians urge Government to secure Evusheld
Over 120 leading clinicians have signed a clinical consensus statement, declaring that the Covid-19 protective antibody treatment Evusheld should be used as soon as possible to protect people most vulnerable to Covid-19.
Making blood cancer and Covid-19 choices that work for you
We know it's still an uncertain time for the blood cancer community, with many people trying to find the right balance between protecting themselves from the virus and looking after their mental well-being.
Survey highlights forgotten pandemic victims
As the country as a whole returns to normal, a quarter of people with blood cancer remain anxious about leaving their home
People affected by blood cancer help decide what research we fund
For the first time at Blood Cancer UK, this year a group of 16 people affected by blood cancer reviewed all applications received by us for research funding.
Blood Cancer UK's partnerships strategy
Discover how Blood Cancer UK is refreshing its partnerships strategy to account for the changing landscape since the COVID-19 pandemic.
Blood Cancer UK's community outreach strategy
Read about Blood Cancer UK's strategy to reach and support more people with blood cancer.
Meet some of our incredible volunteers
Our volunteer co-ordinator introduces some of the incredible volunteers she's met in the role.
Evusheld – is it effective?
In this blog, we talk about what the latest research is telling us about how effective Evusheld is.
Blood Cancer UK's research strategy
Since Blood Cancer UK was formed in 1960, it has invested over £500m in lifesaving blood cancer research.
This is Blood Cancer
Saturday 28 May is World Blood Cancer Day and we’re delighted to be able to share this new, hour-long documentary including films from Blood Cancer UK and other partners.
Our position on Evusheld
Since Evusheld was approved for use by MHRA, we’ve heard from the blood cancer community that one of their greatest concerns is the delay in its rollout across the UK. We wanted to address this directly and explain the work we’ve been doing.
One in 22 Covid deaths are in people with blood cancer
According to new data from the Office of National Statistics, 1 in every 22 people who died of Covid in England and Wales between January and March had blood cancer.
Blood Cancer UK's strategy
Read Blood Cancer UK's update on our organisational strategy.
We're funding 13 new research projects
Find out more about the latest blood cancer research projects that will receive £3 million pounds of funding from Blood Cancer UK
Our audiences: who should we be talking to?
As part of Blood Cancer UK's new organisational strategy, we looked at how we can define and develop our audiences so we can work towards our vision of beating blood cancer.
